News
Abzena upgrades GMP chemistry and conjugation suites to allow Phase III and commercial manufacturing
Abzena, a global partner research organization for integrated bench to market solutions for biologics and bioconjugates, has announced upgrades of its chemistry GMP suites.
The Bristol PA site manufacturing facility upgrades allow Abzena’s ADC client projects to seamlessly progress from...
News
CPhI & P-MEC China 2020 adapts to customer needs with hybrid pharma event
CPhI & P-MEC China returns as a hybrid event in Shanghai (16-18 December, 2020), with a physical exhibition running alongside Virtual Expo Connect (18 November – 18 December, 2020) for international audiences unable to attend.
The physical exhibition will be...
News
SIRIO launches first smart nutra factory in Ma’anshan
SIRIO – a leading nutraceutical contract development and manufacturing organisation (CDMO) – has completed a new ‘smart factory’ at its Ma’anshan site, with Internet of Things (IoT) enabled automated processes and monitoring, intelligent distribution robotics and Artificial intelligence (AI).
Sirio...
News
Onyx Scientific prepares for commercial API license with UK facility investment
Onyx Scientific has announced it is investing in a new facility at its UK site in order to prepare for the approval of a commercial API license.
The new facility, which represents a £3m investment, is currently in the design...
News
New RF Series Benchtop Bottle / Vial Filler Robot for Liquid Filling and Capping Operations
Dispense Works Inc. now offers the RF 2415 Robot that will streamline your filling and capping operations with one precise and affordable bench top package. This dispensing machine is able to process bottles, tubes, vials with caps screwed on...
News
New guidelines for independent batch control of COVID-19 vaccines by EU laboratories
Three new Official Control Authority Batch Release (OCABR) guidelines outlining the tests to be performed by the EU’s Official Medicines Control Laboratories (OMCLs) will be part of the independent control of COVID-19 vaccine batches, when they become available in...
Drug Research
Pioneering research potentially reveals early detection of prostate cancer
Pioneering research conducted by University of Virginia in collaboration with Manchester UK based APIS Assay Technologies Ltd has discovered Hormone-Upregulated lncRNA within the lymphocyte-specific protein tyrosine kinase (HULLK) is detectable in non-invasive prostate cancer patient samples.
The breakthrough data provides...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















